Codar
Product Images NDC 60575-515

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Codar (NDC 60575-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Respa Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Codar D Packaging (Mm1)

Label for Codar D cough suppressant and nasal decongestant syrup, berry flavor, manufactured by Respa Pharmaceuticals in Addison, IL. The label includes active ingredients codeine phosphate 8 mg and pseudoephedrine HCl 30 mg per 5 mL dose, tamper-evident foil seal instruction, storage conditions, and a Drug Facts panel with indications, warnings, and usage information.*

FDA Label Image

Codar D Packaging (Mm2)

This image shows the continuing sections of Drug Facts for CODAR D, including warnings to ask a doctor before use if taking sedatives or tranquilizers, potential for aggravated constipation, and instructions to stop use and seek medical advice for specific symptoms. Dosage directions are provided for different age groups, with recommendations against use in children under 6 years. Additional inactive ingredients are listed, along with storage instructions and the manufacturer information for Respa Pharmaceuticals, Addison, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.